Cargando…

ABCD‐GENE Score and Clinical Outcomes Following Percutaneous Coronary Intervention: Insights from the TAILOR‐PCI Trial

BACKGROUND: In TAILOR‐PCI, genotype‐guided selection of P2Y(12) inhibitors after percutaneous coronary intervention did not significantly reduce the risk of ischemic events at 12 months. The Age, Body Mass Index, Chronic Kidney Disease, Diabetes, and Genotyping (ABCD‐GENE) score identifies patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Capodanno, Davide, Angiolillo, Dominick J., Lennon, Ryan J., Goodman, Shaun G., Kim, Sang‐Wook, O'Cochlain, Fearghas, So, Derek Y., Sweeney, John, Rihal, Charanjit S., Farkouh, Michael, Pereira, Naveen L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245815/ https://www.ncbi.nlm.nih.gov/pubmed/35132875 http://dx.doi.org/10.1161/JAHA.121.024156

Ejemplares similares

Sex‐Specific Differences in Clinical Outcomes After Percutaneous Coronary Intervention: Insights from the TAILOR‐PCI Trial
por: Madan, Mina, et al.
Publicado: (2022)

Rationale and design of the TAILOR-PCI digital study: Transitioning a randomized controlled trial to a digital registry
por: Pereira, Naveen L., et al.
Publicado: (2021)

Patient Onboarding and Engagement to Build a Digital Study After Enrollment in a Clinical Trial (TAILOR-PCI Digital Study): Intervention Study
por: Avram, Robert, et al.
Publicado: (2022)

Digital Tool-Assisted Hospitalization Detection in the Tailored Antiplatelet Initiation to Lessen Outcomes due to Decreased Clopidogrel Response After Percutaneous Coronary Intervention Study Compared to Traditional Site-Coordinator Ascertainment: Intervention Study
por: Avram, Robert, et al.
Publicado: (2023)

Intravenous antiplatelet therapies (glycoprotein IIb/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical use
por: Capodanno, Davide, et al.
Publicado: (2019)

Tailoring P2Y(12) Inhibiting Therapy in Elderly Patients With Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Capranzano, Piera, et al.
Publicado: (2019)

When Less Becomes More: Insights on the Pharmacodynamic Effects of Aspirin Withdrawal in Patients With Potent Platelet P2Y(12) Inhibition Induced by Ticagrelor
por: Capodanno, Davide, et al.
Publicado: (2020)

Low Body Mass Index, Serum Creatinine, and Cause of Death in Patients Undergoing Percutaneous Coronary Intervention
por: Goel, Kashish, et al.
Publicado: (2016)

Platelet thrombin receptor antagonism and atherothrombosis
por: Angiolillo, Dominick J., et al.
Publicado: (2010)

Evolving paradigms in antithrombotic therapy for anticoagulated patients undergoing coronary stenting
por: Buccheri, Sergio, et al.
Publicado: (2019)

Coronavirus Disease 2019–Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management
por: Ortega‐Paz, Luis, et al.
Publicado: (2021)

Role of endothelin in microvascular dysfunction following percutaneous coronary intervention for non-ST elevation acute coronary syndromes: a single-centre randomised controlled trial
por: Guddeti, Raviteja R, et al.
Publicado: (2016)

Utility of MitraClip XTR System in Percutaneous Edge-To-Edge Mitral Valve Repair for Severe Flail Leaflet
por: Al-Hijji, Mohammed, et al.
Publicado: (2020)

The Role of Antiplatelet Therapy in Patients With MINOCA
por: Ortega-Paz, Luis, et al.
Publicado: (2022)

Editorial: Precision medicine for antithrombotic therapy in patients after percutaneous coronary interventions
por: Galli, Mattia, et al.
Publicado: (2023)

P2Y(12) Inhibitor Monotherapy after Percutaneous Coronary Intervention
por: Zhou, Xuan, et al.
Publicado: (2022)

Stroke After Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention: Incidence, Pathogenesis, and Outcomes
por: Gaudino, Mario, et al.
Publicado: (2019)

Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation: Findings From the CONNECT AF+PCI Study
por: Valle, Felipe H., et al.
Publicado: (2021)

Long-term outcomes after fractional flow reserve-guided percutaneous coronary intervention in patients with severe coronary stenosis
por: Zhang, Ying-Hua, et al.
Publicado: (2019)

Effect of genotype-guided strategy in East Asian vs. Caucasian patients after percutaneous coronary intervention: insight from the TAILOR-PCI trial
por: Kim, Hyun Kuk, et al.
Publicado: (2020)

Cangrelor: Clinical Data, Contemporary Use, and Future Perspectives
por: De Luca, Leonardo, et al.
Publicado: (2021)

Safety and Efficacy of Double Antithrombotic Therapy With Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta‐Analysis
por: Capodanno, Davide, et al.
Publicado: (2020)

Escalation and De-Escalation of Antiplatelet Therapy after Acute Coronary Syndrome or PCI: Available Evidence and Implications for Practice
por: Gragnano, Felice, et al.
Publicado: (2022)

Clinical Pharmacokinetics and Pharmacodynamics of CSL112
por: Ortega-Paz, Luis, et al.
Publicado: (2023)

Tailored Antiplatelet Therapy in Patients Undergoing PCI: Is Rapid Bedside Genetic Testing the Answer?
por: Faxon, David P.
Publicado: (2020)

PCI compliance: understand and implement effective PCI data security standard compliance
por: Williams, Branden R, et al.
Publicado: (2015)

Assessment of Equity in Access to Percutaneous Coronary Intervention (PCI) Centres in Poland
por: Rój, Justyna, et al.
Publicado: (2020)

TEST ON ABCD CHIPS
por: Ferrère, D, et al.
Publicado: (1998)

ABCD (who's who)
Publicado: (2009)

Identification of novel SNPs of ABCD1, ABCD2, ABCD3, and ABCD4 genes in patients with X-linked adrenoleukodystrophy (ALD) based on comprehensive resequencing and association studies with ALD phenotypes
por: Matsukawa, Takashi, et al.
Publicado: (2010)

Impact of Hospital Volume of Percutaneous Coronary Intervention (PCI) on In-Hospital Outcomes in Patients with Acute Myocardial Infarction: Based on the 2014 Cohort of the Korean Percutaneous Coronary Intervention (K-PCI) Registry
por: Kim, Byong-Kyu, et al.
Publicado: (2020)

The Hypercholesterolemia Paradox in Percutaneous Coronary Intervention: An Analysis of a Multicenter PCI Registry
por: Ueshima, Daisuke, et al.
Publicado: (2018)

Robotic percutaneous coronary intervention (R-PCI): Time to focus on the pros and cons
por: Thirumurugan, E., et al.
Publicado: (2023)

The Current Status of Intervention for Intermediate Coronary Stenosis in the Korean Percutaneous Coronary Intervention (K-PCI) Registry
por: Kim, Jin-Ho, et al.
Publicado: (2019)

ABCD of Safe Dental Practice
por: Babu, K Sunil, et al.
Publicado: (2011)

Non–ST‐Segment–Elevation Myocardial Infarction Among Patients With Chronic Kidney Disease: A Propensity Score–Matched Comparison of Percutaneous Coronary Intervention Versus Conservative Management
por: Bhatia, Subir, et al.
Publicado: (2018)

The ABCD and ABCD2 Scores and the Risk of Stroke following a TIA: A Narrative Review
por: Bhatt, Archit, et al.
Publicado: (2011)

ABCD3-I and ABCD2 Scores in a TIA Population with Low Stroke Risk
por: Ildstad, Fredrik, et al.
Publicado: (2021)

The Second Report from K-PCI Registry: a Step toward Continuous Systemic Monitoring of Korean Percutaneous Coronary Intervention Practice
por: Won, Hoyoun, et al.
Publicado: (2019)

Transcatheter Aortic Valve Replacement Programs: Clinical Outcomes and Developments
por: Kumar, Vinayak, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gme4mbdm91vr5fn4t7fr5klifp